✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals
Market Cap
₹38,959 Cr.
P/E
0.00
Overview
Shareholder Break-up

Trend
  • 1y
  • 2y
  • 4y
  • 5y
  • 10y
  • Promoter
  • Mutual Funds
  • Insurance Companies
  • FII
  • DII-Others
  • Individual < 2 lac
  • Shares Pledged by Promoters(As a % of Total Promoter Holding)
  • Others
Detailed
FAQs on Glenmark Pharmaceuticals Ltd. Shareholdings

The mutual fund holding of Glenmark Pharma is increasing.
The current mutual fund holding in Glenmark Pharma is 12.86% while previous quarter holding is 12.12%.

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness.
Latest quarter promoter holding in Glenmark Pharma is 46.65% and last quarter promoter holding is 46.65%.

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech